(Alliance News) - Michelmersh Brick Holdings PLC on Tuesday said it continues to see positive order intake levels despite seeing a notable slowdown in the construction market since September. Read More
(Alliance News) - Falcon Oil & Gas Ltd on Thursday said it had remained loss-making in the year to date, ahead of a planned takeover by Australian peer Tamboran Resources Corp. Read More
(Alliance News) - Atome PLC on Tuesday said it is working "24/7" with financing partners to hit targets relating to its flagship Villeta project in Paraguay. Read More
(Alliance News) - Schroder British Opportunities Trust PLC on Tuesday reported a decline in its interim net asset value per share, but noted valuations in the private equity sector "remain robust". Read More
(Alliance News) - RC Fornax PLC on Tuesday provided an optimistic outlook for its new financial year, after a quarterly boost in new orders and "operational improvements" at the firm. Read More
(Alliance News) - TPXimpact Holdings PLC on Tuesday reported a narrowed interim loss due to a leaner operating model, as it approaches the end of its three-year transformation plan. Read More
(Alliance News) - Quantum Data Energy PLC on Tuesday said it has made significant progress in procuring funding for its portfolio of flexible generation power projects. Read More
(Alliance News) - Stock prices in London were mixed at midday on Tuesday, with bank gains helping to steady the market. Read More
(Alliance News) - China accused Keir Starmer of making "groundless accusations" on Tuesday, a day after the UK prime minister said he would engage with Beijing but warned China posed a national security threat. Read More
(Alliance News) - The UK budget watchdog has denied being "at war" with the Treasury after the resignation of its boss Richard Hughes. Read More
(Alliance News) - Fulcrum Metals PLC on Tuesday said preliminary results for its Teck-Hughes mine tailings project achieved over 70% in gold and silver recoveries. Read More
(Alliance News) - AstraZeneca PLC on Tuesday announced that its new drug application under US Food & Drug Administration priority review for its selective inhibitor baxdrostat for certain patients has been accepted. Read More
(Alliance News) - AstraZeneca PLC on Tuesday announced that its new drug application under US Food & Drug Administration priority review for its selective inhibitor baxdrostat for certain patients has been accepted. Read More